In today’s recent session, 1.86 million shares of the Nevro Corp (NYSE:NVRO) have been traded, and its beta is 0.98. Most recently the company’s share price was $4.79, and it changed around -$3.9 or -44.89% from the last close, which brings the market valuation of the company to $175.90M. NVRO at last check was trading at a discount to its 52-week high of $22.64, offering almost -372.65% off that amount. The share price’s 52-week low was $7.46, which indicates that the recent value has fallen by an impressive -55.74% since then. We note from Nevro Corp’s average daily trading volume that its 10-day average is 0.51 million shares, with the 3-month average coming to 554.03K.

Nevro Corp stock received a consensus recommendation rating of Buy, based on a mean score of 3.81. If we narrow it down even further, the data shows that 0 out of 10 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 0 recommended NVRO as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight. Nevro Corp is expected to report earnings per share of -0.57 for the current quarter.

Nevro Corp (NYSE:NVRO) trade information

Instantly NVRO has been showing red trend so far today with a performance of -44.89% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 10.07 on recent trading dayincreased the stock’s daily price by 52.43%. The company’s shares are currently down -77.75% year-to-date, but still down -51.77% over the last five days. On the other hand, Nevro Corp (NYSE:NVRO) is -37.07% down in the 30-day period. We can see from the shorts that 3.18 million shares have been sold at a short interest cover period of 5.07 day(s).

The consensus price target as assigned by Wall Street analysts is $40.5, which translates to bulls needing to increase their stock price by 88.17% from its current value. Analyst projections state that NVRO is forecast to be at a low of $5.5 and a high of $125.

Nevro Corp (NVRO) estimates and forecasts

Nevro Corp share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -72.82 percent over the past six months and at a 13.01% annual growth rate that is well above the industry average of 10.90%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 12.30% in revenue this quarter, and will report a decrease of -28.00% in the next quarter. The year-over-year growth rate is expected to be 3.50%, up from the previous year.

Consensus estimates provided by 16 financial analysts predict the company will bring in an average of 107.74M in revenue for the current quarter. 16 analysts expect Nevro Corp to make 123.06M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 103.86M and 116.18M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 3.70%. Forecasts for the next quarter put sales growth at 5.90%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -9.37%.

NVRO Dividends

Nevro Corp’s next quarterly earnings report is expected to be released on 2024-Oct-30.

Nevro Corp (NYSE:NVRO)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 3.78% of Nevro Corp shares, and 109.68% of them are in the hands of institutional investors. The stock currently has a share float of 113.99%. Nevro Corp stock is held by 231.0 institutions, with ARMISTICE CAPITAL, LLC being the largest institutional investor. By 2024-03-31, it held 10.0719% of the shares, which is about 3.62 million shares worth $52.33 million.

BLACKROCK INC., with 9.4895% or 3.41 million shares worth $49.3 million as of 2024-03-31, holds the second largest percentage of outstanding shares.